======= RNF111 ======= == Gene Information == * **Official Symbol**: RNF111 * **Official Name**: ring finger protein 111 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54778|54778]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q6ZNA4|Q6ZNA4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RNF111&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RNF111|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605840|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |zf-rbx1| |zf-C3HC4| |SUMO polymer binding| |ubiquitin-dependent SMAD protein catabolic process| |global genome nucleotide-excision repair| |positive regulation of transforming growth factor beta receptor signaling pathway| |positive regulation of cellular response to transforming growth factor beta stimulus| |SMAD binding| |PML body| |positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |nucleotide-excision repair| |regulation of transforming growth factor beta receptor signaling pathway| |positive regulation of protein ubiquitination| |regulation of cellular response to transforming growth factor beta stimulus| |positive regulation of protein modification by small protein conjugation or removal| |transmembrane receptor protein serine/threonine kinase signaling pathway| |regulation of protein ubiquitination| |ubiquitin protein ligase activity| |regulation of protein modification by small protein conjugation or removal| |regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |regulation of cellular response to growth factor stimulus| |protein polyubiquitination| |pattern specification process| |DNA repair| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |protein-containing complex| |cellular protein catabolic process| |protein catabolic process| |protein ubiquitination| |enzyme linked receptor protein signaling pathway| |DNA metabolic process| |protein modification by small protein conjugation| |cellular response to DNA damage stimulus| |cellular macromolecule catabolic process| |protein modification by small protein conjugation or removal| |macromolecule catabolic process| |organonitrogen compound catabolic process| |positive regulation of transcription by RNA polymerase II| |positive regulation of protein modification process| |proteolysis| |positive regulation of transcription, DNA-templated| |positive regulation of cellular protein metabolic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of signal transduction| |cellular response to stress| |positive regulation of protein metabolic process| |positive regulation of RNA metabolic process| |organic substance catabolic process| |cellular catabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp59|UMK57 1μM R01 exp59]]|-3.06| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-2.08| |[[:results:exp537|WNT3A 44ng/ml R08 exp537]]|-2.07| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-1.87| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|-1.79| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|-1.75| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|-1.72| |[[:results:exp141|Nifurtimox 1μM R03 exp141]]|1.73| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|1.76| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|1.8| |[[:results:exp83|Trametinib 10μM R02 exp83]]|1.85| |[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|1.86| |[[:results:exp429|Rapamycin 0.001μM R08 exp429]]|2.15| |[[:results:exp422|Wiskostatin 3μM R07 exp422]]|2.22| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|2.29| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|2.41| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4102 * **Expression level (log2 read counts)**: 5.67 {{:chemogenomics:nalm6 dist.png?nolink |}}